Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Regulatory News (VER)

  • There is currently no data for VER

AGM Statement

23 May 2007 11:49

Vernalis PLC23 May 2007 23 May 2007 VERNALIS PLC RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 23 MAY 2007 Vernalis plc announces that all resolutions proposed to shareholders at itsAnnual General Meeting held today were duly passed. All resolutions were approved on a show of hands. The number of proxy votesreceived for each resolution is set out below. Resolution For (including Against* Withheld discretionary votes)*Ordinary Resolution1. To receive theaudited accounts and related reports of theDirectors and auditors 224,569,857 (99.99%) 10,707 (0.01%) 7,1572. To approve theremuneration report 217,328,467 (99.63%) 813,306 (0.37%) 6,445,9483. To re-elect as a Director Dr A Baxter 224,545,392 (99.99%) 33,176 (0.01%) 9,1534. To re-elect as a Director Ms C C Ferguson 224,544,267 (99.98%) 38,844 (0.02%) 4,6105. To re-elect asa Director Mr J AD Slater 224,553,615 (99.99%) 28,646 (0.01%) 5,4606. To elect as aDirector Mr I Clark 224,542,703 (99.98%) 35,049 (0.02%) 9,9697. To re-appointPricewaterhouseCoopers LLP as auditors and to authorise the Directors to determine their remuneration 223,611,362 (99.65%) 792,957 (0.35%) 183,4028. To authorise the Directors to allot relevantsecurities 224,537,200 (99.98%) 37,797 (0.02%) 12,724Special Resolution9. To authorise the Directors to allot equitysecurities for cash 224,527,782 (99.98%) 39,519 (0.02%) 20,420Ordinary Resolution10. To approve the Vernalis plc Bonus Long-TermIncentive Plan 199,330,753 (91.39%) 18,789,501 (8.61%) 6,467,467 *NB: Percentage of votes cast excludes withheld votes Enquiries: Vernalis plc +44 (0)118 977 3133Simon Sturge, Chief Executive OfficerTony Weir, Chief Financial Officer Brunswick Group +44 (0)20 7404 5959Jon ColesAlex Tweed This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
18th Mar 20161:06 pmRNSHolding(s) in Company
17th Mar 20167:00 amRNSUnaudited interim results for 6 months to 31/12/15
4th Feb 20163:34 pmRNSNotice of Results for Six Months Ended 31/12/2015
19th Jan 20162:36 pmRNSHolding(s) in Company
6th Jan 20167:00 amRNSVernalis Announces Adenosine Antagonist Licensee
31st Dec 20157:00 amRNSTotal Voting Rights
21st Dec 20157:00 amRNSVernalis Announce CCP-07 Single-Dose Study Results
3rd Dec 20155:19 pmRNSLaunch of 2015 Sharesave Plan
2nd Dec 201511:19 amRNSVernalis Results of Annual General Meeting
2nd Dec 20157:00 amRNSAGM Statement
1st Dec 20154:54 pmRNSHolding(s) in Company
23rd Nov 20155:23 pmRNSHolding(s) in Company
4th Nov 20154:34 pmRNSHolding(s) in Company
30th Oct 20157:00 amRNSTotal Voting Rights
28th Oct 20159:00 amRNSNotice of Annual Report and AGM
15th Oct 20153:54 pmRNSDirector Dealing
15th Oct 20152:02 pmRNSHolding(s) in Company
12th Oct 20157:00 amRNSCCP-08 starts 12 month stability testing
8th Oct 20152:19 pmRNSDirector Dealing
2nd Oct 20157:00 amRNSVernalis plc acquires US rights to MOXATAG®
29th Sep 20157:02 amRNSResults announcement for 18 months ended 30/06/15
25th Sep 201511:09 amRNSBlocklisting Interim Review
16th Sep 20155:08 pmRNSHolding(s) in Company
11th Sep 20157:00 amRNSNotice of Results
8th Sep 20157:00 amRNSVernalis plc Launches Tuzistra(TM) XR
20th Aug 20157:00 amRNSVernalis completes investment in NCE development
18th Aug 20157:00 amRNSAppointment of Non-Executive Director
30th Jun 20151:27 pmRNSAppointment of Non-Executive Director
30th Jun 20157:00 amRNSTotal Voting Rights
12th Jun 20154:34 pmRNSHolding(s) in Company
11th Jun 20157:00 amRNSCCP-07 starts 12 month stability testing
6th May 20151:45 pmRNSBlock Listing Six Monthly Review
6th May 201512:30 pmRNSDirector/PDMR Shareholding
1st May 20154:38 pmRNSHolding(s) in Company
1st May 20157:00 amRNSFDA approves NDA for Tuzistra XR
30th Apr 20153:27 pmRNSHolding(s) in Company
23rd Apr 20152:39 pmRNSHolding(s) in Company
7th Apr 20157:00 amRNSVernalis enters into research collaboration
31st Mar 201512:47 pmRNSTotal Voting Rights
6th Mar 20157:00 amRNSVernalis and AKP Achieve Research Milestone
26th Feb 20157:00 amRNSVernalis licenses proprietary ARA technology
18th Feb 201512:51 pmRNSHolding(s) in Company
10th Feb 20157:00 amRNSUnaudited interim results for periods to 31/12/14
5th Feb 20155:53 pmRNSHolding(s) in Company
30th Jan 201511:50 amRNSNotice of Interim Results Period Ended 31 Dec 2014
26th Jan 20151:06 pmRNSHolding(s) in Company
21st Jan 201511:00 amRNSChange of Non-Executive Director
31st Dec 20147:00 amRNSTotal Voting Rights
19th Dec 20147:00 amRNSUpdate on AUY922 development programme
28th Nov 20147:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.